Aegis Sciences Corporation

A look inside our new lab! This is our commitment to delivering the best in medication monitoring. Through our cutting-edge research and development, Aegis is uniquely equipped to keep pace with the ever-changing drug landscape in support of our mission of helping clinicians make better decisions.

The presence of counterfeit substances containing polysubstances and adulterants continues to vary and grow over time. The general population attempting to use medications recreationally are at an all-time risk of a potentially fatal overdose due to the lethal options available in the illicit drug space. All individuals are at a greater risk of harm when substances are adulterated with multiple compounds. Aegis continues to expand testing to protect the public from unapproved, diverted, or counterfeit drugs presenting overdose risks. Learn more here: https://lnkd.in/g5S-kZXe #AegisLabs #OverdosePrevention #OnePillCanKill #NPS #DrugTesting

It is important to remember both illicit and prescription drugs when focusing on drug-related visits to the ED. According to the 2022 report of the Drug Abuse Warning Network (DAWN), prescription or other opioids were reported in 39.4% of opioid-related ED visits and oxycodone was the most common opioid reported (32.9%). Medication compliance is extremely important to monitor when prescribing opioids or any drug that has the potential for abuse/misuse. Read more here: https://lnkd.in/eynGhXFT Aegis offers an expansive menu for both medication adherence and illicit drug use, including IMF (illegally manufactured fentanyl), xylazine, medetomidine, etc., and the most up-to-date and robust menu of novel psychoactive substances. Learn more today: https://lnkd.in/emXVQJ93 #AegisLabs #AegisEducates #IllicitDrugs #OnePillCanKill #NPS

Nitazene analogs are novel psychoactive substances which are structurally different from fentanyl but attach to the same mu-opioid receptor. Recent studies have demonstrated that drugs within the nitazene class more often than not have greater potency than illicitly manufactured fentanyl, prescription opioids, and other designer opioids. In Aegis’ testing, increasing co-detection of fentanyl, fentanyl analogs, and nitazene analogs demonstrate that the drug supply is becoming more adulterated. Learn more about nitazene analogs by watching a recently recorded webinar here: https://lnkd.in/ejtCHFuc #AegisLabs #AegisEducates #Nitazenes #Fentanyl #Opioids #OnePillCanKill

The illicit drug supply is ever-changing. Illicitly-manufactured fentanyl (IMF) is often found in combination with many substances, including other opioids such as fentanyl analogs and/or nitazene analogs. In many cases, these substances are more potent than fentanyl. Learn more about nitazene analogs by watching this week’s recorded webinar here: https://lnkd.in/ejtCHFuc #AegisLabs #AegisEducates #Nitazenes #NPS #Fentanyl #Opioids #IllicitDrugs #OverdosePrevention #OnePillCanKill #Webinar #Clinical

A recent study showed that designer benzodiazepine use was linked to an increase in morbidity and mortality. Tools to discover the use of designer are available, most notably, enhanced drug testing. Read more here: https://lnkd.in/ecj_vWDa Aegis offers clinicians the ability to detect designer benzodiazepine use in their patients, which affords the opportunity to discuss further risk mitigation. Learn more today: https://lnkd.in/emXVQJ93 #AegisLabs #NPS #DesignerDrugs #OnePillCanKill #OverdosePrevention

Please join us tomorrow, Tuesday, June 25th, as we will be discussing both previous and recent published finding on nitazenes, as well as, trends in Aegis results related to changes in detection of nitazene analogs over time. Register today: https://lnkd.in/ejtCHFuc #AegisLabs #AegisEducates #Nitazenes #NPS #DesignerOpioids #OnePillCanKill #LivePresentation #Webinar #Education #PublicSafety

Please join us on Tuesday, June 25, for an educational webinar hosted by Andrew Holt, PharmD, BCMAS, CPGx, Clinical Pharmacist, Aegis Sciences Corporation. Dr. Holt will discuss new data on Nitazenes, an emerging threat. Register Today: https://lnkd.in/ejtCHFuc #AegisLabs #AegisEducates #Nitazenes #NPS #DesignerOpioids #OnePillCanKill #LivePresentation #Webinar #Education #PublicSafety

Nitazene analogs, a class of illicitly-manufactured opioids that are not approved for human use, are known for their high potency and ability to contribute to adverse events, such as overdose deaths. While illicitly-manufactured fentanyl remains the predominant driver of overdoses in the US, peer-reviewed publications and data reported by surveillance organizations continue to indicate that nitazenes are part of an ongoing public health threat. As novel high-potency opioids continue to garner national and international attention, often resulting in regulation as controlled substances, it is possible that we will continue to see new and different drugs emerge. Testing and monitoring are crucial for understanding and mitigating the impact of these substances on public health. Clinical Update: https://lnkd.in/eY-nPcFx #AegisLabs #AegisEducates #Nitazenes #NPS #DesignerOpioids #OnePillCanKill #PublicSafety

Some healthcare laboratories are starting to expand Novel Psychoactive Substance or NPS testing, even adding some of the fentanyl analogs to their offering, but Aegis has purposefully explored addition of relevant nitazene compounds within our designer opioid menu to ensure we are offering relevant testing. Join us on Tuesday, June 25th, for our monthly clinical webinar presented by Dr. Holt as we discuss new data on nitazenes and ongoing evaluation of this emerging threat. Register Today: https://lnkd.in/ejtCHFuc #AegisLabs #Nitazenes #DesignerOpioids #NPS #OnePillCanKill #PublicSafety #Webinar #LivePresentation #Clinical #Education